Research Roundup ยท 2026

Reference Hub: Prognosis and treatment of Reglan-related Tardive Dyskinesia

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Recommended deep-dive

A Closer Look at Prognosis and treatment of Reglan-related Tardive Dyskinesia

A focused look at the background, context, and key sources on this subject.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.